A safety and feasibility study of limited cardiac monitoring during non-anthracycline trastuzumab-based therapy in patients with HER2-positive breast cancer
NCT ID NCT03983382
First seen May 16, 2026 · Last updated May 16, 2026
Summary
The purpose of this study is to test whether patients with breast cancer who are being treated with non-anthracycline trastuzumab therapy can safely be monitored for heart related side effects less often than usual.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only)
Hartford, Connecticut, 06102, United States
-
Memorial Sloan Kettering Bergen (Consent and follow-up only)
Montvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Center @ BaskingRidge (Consent and follow-up only)
Basking Ridge, New Jersey, 07920, United States
-
Memorial Sloan Kettering Cancer Center @ Commack (Consent and Follow up)
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Monmouth (Consent and Follow up)
Middletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau (Consent and Follow-up)
Rockville Centre, New York, 11553, United States
-
Memorial Sloan Kettering Westchester (Consent and Follow-up)
Harrison, New York, 10604, United States
Conditions
Explore the condition pages connected to this study.